A new study from the American Academy of Pediatrics now recommends genome and exome sequencing as first-line diagnostic tests for children with neurodevelopmental disorders to improve early diagnoses and ensure comprehensive care. Scott Demarest, MD, Chief Precision Medicine Officer, comments on his experience.